Traditional Chinese Herb Coptis Blocks the LL-37 Pathway Driving Rosacea Inflammation
Coptis chinensis extract reduced rosacea-related inflammation by inhibiting KLK5 enzyme activity and blocking the conversion of inactive cathelicidin into the inflammatory LL-37 peptide.
Quick Facts
What This Study Found
Coptis chinensis downregulated KLK5 and cathelicidin expression, inhibited KLK5 protease activity (reducing LL-37 processing), decreased pro-inflammatory cytokines, blocked TLR2/chitin signaling, and inhibited LL-37-induced endothelial cell proliferation.
Key Numbers
Reduced KLK5 expression and activity; reduced cathelicidin and LL-37 processing; blocked TLR2 from Demodex chitin; inhibited endothelial proliferation
How They Did This
In vitro study using human epidermal keratinocytes and microvascular endothelial cells. Tested CC effects on KLK5/cathelicidin expression and activity, LL-37 processing, inflammatory cytokine production, TLR2 signaling (chitin stimulation), and endothelial proliferation.
Why This Research Matters
Rosacea affects millions and current treatments are limited. Understanding how a traditional remedy targets the specific LL-37/KLK5 pathway behind rosacea could lead to more effective, mechanism-based treatments.
The Bigger Picture
This study provides molecular evidence for a traditional medicine's efficacy in rosacea, connecting it to the now well-established cathelicidin/LL-37 overexpression pathway that drives rosacea pathogenesis.
What This Study Doesn't Tell Us
In vitro only — no clinical trial data. Herb extract composition may vary; active compounds not isolated. Bioavailability after topical application unknown. Single keratinocyte cell line used.
Questions This Raises
- ?Which specific compounds in Coptis chinensis are responsible for KLK5/LL-37 inhibition?
- ?Would a topical Coptis formulation show clinical improvement in rosacea patients?
- ?Does Coptis over-suppress LL-37 to levels that would impair skin antimicrobial defense?
Trust & Context
- Key Stat:
- Multi-target rosacea action Coptis chinensis inhibits KLK5 activity, LL-37 processing, TLR2 signaling, and angiogenesis — all key rosacea drivers
- Evidence Grade:
- Preliminary — in vitro mechanistic evidence supporting traditional use, but no clinical validation in rosacea patients.
- Study Age:
- Published in 2020; the LL-37/KLK5 pathway remains a central target in rosacea research and drug development.
- Original Title:
- Coptis chinensis Franch Directly Inhibits Proteolytic Activation of Kallikrein 5 and Cathelicidin Associated with Rosacea in Epidermal Keratinocytes.
- Published In:
- Molecules (Basel, Switzerland), 25(23) (2020)
- Authors:
- Roh, Kyung-Baeg, Ryu, De-Hun, Cho, Eunae, Weon, Jin Bae, Park, Deokhoon, Kweon, Dae-Hyuk, Jung, Eunsun
- Database ID:
- RPEP-05097
Evidence Hierarchy
Frequently Asked Questions
How does LL-37 cause rosacea if it is supposed to be a defense peptide?
LL-37 normally protects skin from infection, but in rosacea, it is overproduced and over-processed by the enzyme KLK5. Excess LL-37 triggers inflammation, promotes blood vessel growth (causing redness), and activates immune responses — all hallmarks of rosacea.
Is Coptis chinensis safe for rosacea treatment?
Coptis chinensis (goldthread) has a long history of use in traditional Chinese medicine for inflammatory skin conditions. While this study provides a scientific mechanism, clinical trials are needed to confirm safety and efficacy specifically for rosacea.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05097APA
Roh, Kyung-Baeg; Ryu, De-Hun; Cho, Eunae; Weon, Jin Bae; Park, Deokhoon; Kweon, Dae-Hyuk; Jung, Eunsun. (2020). Coptis chinensis Franch Directly Inhibits Proteolytic Activation of Kallikrein 5 and Cathelicidin Associated with Rosacea in Epidermal Keratinocytes.. Molecules (Basel, Switzerland), 25(23). https://doi.org/10.3390/molecules25235556
MLA
Roh, Kyung-Baeg, et al. "Coptis chinensis Franch Directly Inhibits Proteolytic Activation of Kallikrein 5 and Cathelicidin Associated with Rosacea in Epidermal Keratinocytes.." Molecules (Basel, 2020. https://doi.org/10.3390/molecules25235556
RethinkPeptides
RethinkPeptides Research Database. "Coptis chinensis Franch Directly Inhibits Proteolytic Activa..." RPEP-05097. Retrieved from https://rethinkpeptides.com/research/roh-2020-coptis-chinensis-franch-directly
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.